Primary bone lymphoma of the distal femur – a case report

Praloy Basu

doi:10.18203/issn.2455-4510.IntJResOrthop20254241

Authors

Praloy Basu Department of Medical Oncology, Desun Hospital, Kolkata, West Bengal, India

DOI:

https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20254241

Keywords:

Primary bone lymphoma, Diffuse large B-cell lymphoma, R-CHOP chemoimmunotherapy, Involved-field radiotherapy, PET-CT

Abstract

Primary bone lymphoma (PBL) is a rare extranodal lymphoma that arises within skeletal structures, most often as diffuse large B-cell lymphoma (DLBCL). It typically presents with localized pain and swelling and requires a high index of suspicion for diagnosis. A 53-year-old man presented with pain and swelling over the distal femur. Imaging revealed a lytic-sclerotic lesion with cortical breach and soft-tissue extension. Biopsy confirmed large B-cell lymphoma, germinal center subtype. Staging workup showed no nodal or marrow involvement, consistent with Stage IE disease. The patient was treated with one cycle of CVP followed by six cycles of Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin and Prednisone (R-CHOP) and involved-field radiotherapy (40 Gy/20 fractions). Post-treatment positron emission tomography-computed tomography (PET-CT) showed complete metabolic response. Combined-modality treatment with R-CHOP chemoimmunotherapy and radiotherapy offers excellent outcomes in localized PBL. Early diagnosis, accurate staging, and multidisciplinary management are crucial for durable remission and optimal survival.

Metrics

Metrics Loading ...

References

Ventre MB, Ferreri AJM, Gospodarowicz M, Govi S, Messina C, Porter D, et al. Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study). Oncologist. 2014;19(3):291-8. DOI: https://doi.org/10.1634/theoncologist.2013-0249

Jawad MU, Schneiderbauer MM, Min ES, Cheung MC, Koniaris LG, Scully SP. Primary lymphoma of bone in adult patients. Cancer. 2010;116(4):871-9. DOI: https://doi.org/10.1002/cncr.24828

Mulligan ME, McRae GA, Murphey MD. Imaging features of primary lymphoma of bone. AJR Am J Roentgenol. 1999;173(6):1691-7. DOI: https://doi.org/10.2214/ajr.173.6.10584821

Stokes SH, Walz BJ. Pathologic fracture after radiation therapy for primary non-Hodgkin’s malignant lymphoma of bone. Int J Radiat Oncol Biol Phys. 1983;9(8):1153-9. DOI: https://doi.org/10.1016/0360-3016(83)90173-6

Jain A, Alam K, Maheshwari V, Khan R, Nobin H, Narula V. Primary bone lymphomas: Clinical cases and review of literature. J Bone Oncol. 2013;2(3):132-6. DOI: https://doi.org/10.1016/j.jbo.2013.07.003

Beal K, Allen L, Yahalom J. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer. 2006;106(12):2652-6. DOI: https://doi.org/10.1002/cncr.21930

Tao R, Allen PK, Rodriguez A, Shihadeh F, Pinnix CC, Arzu I, et al. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma. Int J Radiat Oncol Biol Phys. 2015;92(1):122-9. DOI: https://doi.org/10.1016/j.ijrobp.2015.01.014

Cai L, Stauder MC, Zhang YJ, Poortmans P, Li YX, Constantinou N, et al. Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) study. Int J Radiat Oncol Biol Phys. 2012;83(1):284-91. DOI: https://doi.org/10.1016/j.ijrobp.2011.06.1976

Ramadan KM, Shenkier T, Sehn LH, Gascoyne RD, Connors JM. A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol. 2007;18(1):129-35. DOI: https://doi.org/10.1093/annonc/mdl329

Rathmell AJ, Gospodarowicz MK, Sutcliffe SB, Clark RM. Localised lymphoma of bone: prognostic factors and treatment recommendations. Br J Cancer. 1992;66(3):603-6. DOI: https://doi.org/10.1038/bjc.1992.322

Fidias P, Spiro I, Sobczak ML, Nielsen GP, Ruffolo EF, Mankin H, et al. Long-term results of combined-modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys. 1999;45(5):1213-8. DOI: https://doi.org/10.1016/S0360-3016(99)00305-3

Ma S, Zhang Y, Li Z, Yan H, Xia L, Shi W, Hu Y. Role of radiation therapy differs between stages in primary bone large B-cell lymphoma in rituximab era: a population-based analysis. Front Oncol. 2020;10:1157. DOI: https://doi.org/10.3389/fonc.2020.01157

Wu H, Bui MM, Leston DG, Shao H, Sokol L, Sotomayor EM, Zhang L. Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas. BMC Cancer. 2014;14:900. DOI: https://doi.org/10.1186/1471-2407-14-900

Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059-68. DOI: https://doi.org/10.1200/JCO.2013.54.8800

Oberling C. Les reticulosarcomes et les reticuloendotheliosarcomes de la moelle osseuse (sarcoma d’Ewing). Bull Assoc Fr Etud Cancer. 1928;17:259-96.